期刊文献+

氨基末端脑钠素前体(NT-proBNP)在风心病合并心力衰竭患者中检测的临床意义 被引量:1

Plasma NT-proBNP levels and its clinical significance in patients with rheumatic heart disease
下载PDF
导出
摘要 目的 观察在风心病合并心力衰竭患者中NT -proBNP的水平变化,探讨NT- proBNP用于评价风心病心功能异常的临床意义。方法 纳入风心病合并心力衰竭的患者42例以及正常对照17例,采用电化学发光法检测NT -proBNP浓度,同时采用超声心动图及彩色超声多普勒测定左室舒末内径、左房、右房和右室内径以及左室的射血分数,以单因素方差分析(ANOVA法)比较NT proBNP在风心病患者中不同NYHA分级间的差异,同时采用多因素相关分析寻找影响NT -proBNP水平的相关因素。结果 风心病患者中NT- proBNP浓度显著高于对照组(P <0 .0 1) ,在风心病患者中NT proBNP浓度随NYHA分级的升高而显著地升高(P <0 .0 5 ) ,但是多因素相关分析仅发现NT proBNP与左室舒末内径有微弱的正相关趋势(r =0 .3 0 4,P =0 .0 76) ,而同左房内径、右房、右室内径、射血分数等指标间无明显的相关性。结论 风心病合并心力衰竭患者中NT- proBNP显著升高,这一异常同心力衰竭的严重度有一定关系,但是同左室收缩功能以及心脏结构异常程度无显著的相关性。 Objective To measure NT-proBNP levels in patients with RHD and to determine whether NT-proBNP concentrations correlate with clinical and echocardiographic findings.Methods 42 patients with rheumattic valve disease and 17 healthy subjects were entered in the study.NT-proBNP was measured using the commercially available assay-kits(Roche,USA).Transthoracic echocardiography was performed in all patients to assess the severity of the valve disease and for the measurement of LVDD,diameter of LA,LV,RA,RV and LVEF.Results The plasma concentrations of NT-BNP were significantly higher in patients with rheumatic heart disease than in control subjects (P<0.01).The plasma NT-BNP level was significantly increased with upgrading of NYHA class(P<0.05).There was a mild correlationship between higher NT-proBNP and LVDD in multivariate analysis.Conclusion We found increased plasma BNP levels in patients with rheumatic heart disease compared with healthy subjects.And the abnormality is related to the severity of heart failure (NYHA class).
出处 《四川医学》 CAS 2005年第5期491-493,共3页 Sichuan Medical Journal
关键词 风心病 氨基末端脑钠素前体(NT-proBNP) 心力衰竭 临床意义 rheumati heart disease NT-proBNP heart failure clinical significance
  • 相关文献

参考文献8

  • 1Vanderheyden M,Goethals M,Verstreken S,et al.Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy [J].J Am Coll Cardiol,2004,44(12):2349~2354.
  • 2高伟,王士雯,赵玉生.脑钠肽前体N末端片段在心血管病研究应用中的现状[J].中华心血管病杂志,2004,32(8):759-761. 被引量:65
  • 3Yoshihiko S,Akio O,Teruyo Y,et al.Application of NT-proBNP and BNP measurements in cardiac care:a more discerning marker for the detection and evaluation of heart failure [J].The European Journal of Heart Failure,2004(6):295~300.
  • 4Grantham JA,Burnett JC.BNP:increasing importance in the pathophysiology and diagnosis of congestive heart failure [J].Circulation,1997,96:3882~3890.
  • 5Lee SC,Stevens TL,Sandberg SM,et al.The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure [J].J Card Fail,2002,8(3):149~154.
  • 6Logeart D,Saudubray C,Beyne P,et al.Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea [J].J Am Coll Cardiol,2002,40(10):1794~1800.
  • 7Golbasy Z,Ucar O,Yuksel AG,et al.Plasma brain natriuretic peptide levels in patients with rheumatic heart disease [J].Eur J Heart Fail,2004,6(6):757~760.
  • 8Eimer MJ,Ekery DL,Rigolin VH,et al.Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function [J].Am J Cardiol,2004,94(5):676~678.

二级参考文献10

  • 1Talwar S,Downie PF,Squire IB,et al.Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis[].European Journal of Heart Failure.2001
  • 2Jernberg T,Stridsberg M,Venge P,et al.N-terminal pro-brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation[].Journal of the American College of Cardiology.2002
  • 3Luchner A,Hengstenberg C,Lowel H,et al.N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function[].Journal of Hypertension.2002
  • 4Bay M,Kirk V,Parner J,et al.NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function[].Heart.2003
  • 5Pemberton CJ,Johnson ML,Yandle TG,et al.Deconvolution analysis of cardiac natri uretic peptides during acute volume overload[].Journal of Hypertension.2000
  • 6Campbell DJ,Munir V,Hennessy OF,et al.Plasma amino-terminal pro-brain natriuretic peptide levels in subjects presenting to the Emergency Department with suspected acute coronary syndrome: possible role in selecting patients for follow up[].International Medical Journal.2001
  • 7Karl J,Borgya A,Gallusser A,et al.Development of a novel, N-terminal-proBNP ( NT-proBNP) assay with a low detection limit[].Scandinavian Journal of Clinical and Laboratory Investigation.1999
  • 8Pemberton CJ,Yandle TG,Charles CJ,et al.Ovine brain natriuretic peptide in cardiac tissues and plasma: effects of cardiac hypertrophy and heart failure on tissue concentration and molecular forms[].The Journal of Endocrinology.1997
  • 9Sudoh T,Kangawa K,Minamino N,et al.A natriuretic peptide in porcine brain[].Nature.1988
  • 10Nilsson JC,Groenning BA,Nielsen G,et al.Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide[].American Heart Journal.2002

共引文献64

同被引文献18

  • 1陈铃,朱红枫.氨基末端脑钠尿肽激素原对小儿心功能的评估[J].中国妇幼健康研究,2006,17(3):202-205. 被引量:2
  • 2Mir TS, Marohn S, Laer S,et al. Plasm concentrations of N - terminalpro - brain natriuretie peptide in control children from the neonatal to adolescent period and in children with congestive heartfailure[ J]. Pediatrics ,2002,110 (6) : E76.
  • 3Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B -type natri- uretic peptide assay accurately diagnoses left ventricutar dysfunction and heart failure: a muhicenter evaluation [ J ]. Am Heart J ,2002,144 (5) :834 -839.
  • 4Cushing SD,Berliner JA, Valente AJ,et al. Minimally modified low density lipoprotein induces monocyte chemotactie protein 1 in human endothelial cells and smoth muscle cells[ J]. Proc Nail Acad Sci, 1990,87(13) :5134 -5138.
  • 5Oishi IY, Wakatsuki T, Nishikado A,et al. Circulating adhesion mole- cules and severity of coronary atherosclerosis[ J]. Coron Artery Dis, 2000,11(1) :77 -81.
  • 6I Maisela S, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B - type natriuretic peptide in the emergency diagnosis of heart failure [J]. N Eng J Med,2002,347:161 -167.
  • 7Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of ma- trix metalloproteinases and matrix degrading activity in vulnerable re- gions of human atheresclerotic plaqus[J]. J Clin Invest, 1994,94 (6) :2493 -2503.
  • 8Pcng HB ,Libby P, Liao JK. Induction and stabilization of 1 kappa B alpha by nitric oxide mediates inhibition of NF -kappa B[ J]. J Biol Chem, 1995,270 (23) : 14214 - 14219.
  • 9Januzzi JL, Camargo CA,Anwaruddin S, et al. The N - terminal pro - BNP investiation of dyspnea in the emereney department ( PRIDE ) study[ J]. Am J Cardiol,2005,95(8) :948 -954.
  • 10Logeart D, Saudubray C, Beyne P, et al. Comparative value of Doppler echocardiography and B - type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea [ J ]. J Am Coil Cardiol, 2002,40(10) : 1794 - 1800.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部